Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort

被引:35
|
作者
Gambier, N
Batt, AM
Marie, B
Pfister, M
Siest, G
Visvikis-Siest, S
机构
[1] Univ Nancy 1, INSERM, Fac Pharm, U525, F-54000 Nancy, France
[2] Ctr Med Prevent, Vandoeuvre Les Nancy, France
来源
PHARMACOGENOMICS JOURNAL | 2005年 / 5卷 / 04期
关键词
CYP2A6; genetic; polymorphism; nicotine; smoking; French population;
D O I
10.1038/sj.tpj.6500314
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study was designed in order to investigate the influence of the genetic polymorphism of CYP2A6 on the amount of smoking. In all, 463 French adults included in the Stanislas cohort were studied and underwent two examinations at 5 years distance (t(0) and t(+5) years). Information on their smoking habits was collected. They were genotyped by RFLP for the CYP2A6*1A, CYP2A6*1B and CYP2A6*4 alleles. CYP2A6*1B and CYP2A6*4 allele frequencies were 32 and 4%, respectively. The subjects carrying the CYP2A6*1B allele oxidize nicotine to cotinine faster than subjects with the CYP2A6*1A allele. The number of cigarettes smoked per day was significantly higher in the CYP2A6*1B/*1B group as compared to the CYP2A6*1A/*1A group (P = 0.01 at t(0); P = 0.001 t(+5) years), with a larger increase in their daily cigarettes consumption over the 5-year period (P = 0.006). No significant difference in the smoking status was observed according to the CYP2A6 genotype. These data suggest thatthe CYP2A6*1B is associated with the number of cigarettes smoked per day.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 50 条
  • [1] Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort
    N Gambier
    A-M Batt
    B Marie
    M Pfister
    G Siest
    S Visvikis-Siest
    [J]. The Pharmacogenomics Journal, 2005, 5 : 271 - 275
  • [2] Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C
    Ariyoshi, N
    Takahashi, Y
    Miyamoto, M
    Umetsu, Y
    Daigo, S
    Tateishi, T
    Kobayashi, S
    Mizorogi, Y
    Loriot, MA
    Stücker, I
    Beaune, P
    Kinoshita, M
    Kamataki, T
    [J]. PHARMACOGENETICS, 2000, 10 (08): : 687 - 693
  • [3] Identification of novel CYP2A6*1B variants:: The CYP2A6*1B allele is associated with faster in vivo nicotine metabolism
    Mwenifumbo, J. C.
    Lessov-Schlaggar, C. N.
    Zhou, Q.
    Kranow, R. E.
    Swan, G. E.
    Benowitz, N. L.
    Tyndale, R. F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 115 - 121
  • [4] An association of CYP2A6 genotype and smoking topography
    Strasser, Andrew A.
    Malaiyandi, Viba
    Hoffmann, Ewa
    Tyndale, Rachel F.
    Lerman, Caryn
    [J]. NICOTINE & TOBACCO RESEARCH, 2007, 9 (04) : 511 - 518
  • [5] Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults
    Ando, M
    Hamajima, N
    Ariyoshi, N
    Kamataki, T
    Matsuo, K
    Ohno, Y
    [J]. JOURNAL OF EPIDEMIOLOGY, 2003, 13 (03) : 176 - 181
  • [6] Genetic variation of CYP2A6, smoking, and risk of cancer
    London, SJ
    Idle, JR
    Daly, AK
    Coetzee, GA
    [J]. LANCET, 1999, 353 (9156): : 898 - 899
  • [7] CYP2A6 metabolism in the development of smoking behaviors in young adults
    Olfson, Emily
    Bloom, Joseph
    Bertelsen, Sarah
    Budde, John P.
    Breslau, Naomi
    Brooks, Andrew
    Culverhouse, Robert
    Chan, Grace
    Chen, Li-Shiun
    Chorlian, David
    Dick, Danielle M.
    Edenberg, Howard J.
    Hartz, Sarah
    Hatsukami, Dorothy
    Hesselbrock, Victor M.
    Johnson, Eric O.
    Kramer, John R.
    Kuperman, Samuel
    Meyers, Jacquelyn L.
    Nurnberger, John
    Porjesz, Bernice
    Saccone, Nancy L.
    Schuckit, Marc A.
    Stitzel, Jerry
    Tischfield, Jay A.
    Rice, John P.
    Goate, Alison
    Bierut, Laura J.
    [J]. ADDICTION BIOLOGY, 2018, 23 (01) : 437 - 447
  • [8] CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians
    Vasconcelos, GM
    Struchiner, CJ
    Suarez-Kurtz, G
    [J]. PHARMACOGENOMICS JOURNAL, 2005, 5 (01): : 42 - 48
  • [9] CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians
    G M Vasconcelos
    C J Struchiner
    G Suarez-Kurtz
    [J]. The Pharmacogenomics Journal, 2005, 5 : 42 - 48
  • [10] Association of smoking with cadmium induction of hepatic CYP2A6 in humans
    Satarug, Soisungwan
    Moore, Michael R.
    [J]. TOXICOLOGY LETTERS, 2006, 164 : S284 - S284